1mg, best e pharmacy in India


MRP: Rs. 164.78 for 1 strip(s) (10 tablets each)
Unfortunately, we don't have any more items in stock
Report Error

Composition for EUREPA MF

Repaglinide(2 mg),Metformin(500 mg)

food interaction for EUREPA MF

alcohol interaction for EUREPA MF

pregnancy interaction for EUREPA MF

lactation interaction for EUREPA MF

There is no data available. Please consult doctor before consuming the drug.
Taking repaglinide with alcohol may affect blood glucose levels in patients with diabetes.
Taking metformin with alcohol may cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, somnolence, abdominal upset, or other unusual symptoms.
Eurepa mf 2 mg/500 mg tablet may be unsafe to use during pregnancy.
Either animal studies have shown adverse effect on fetus and there are no human studies or studies in human and animals are not available. It should be given only if potential benefits justifies risk to the fetus. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.


Repaglinide(2 mg)


Repaglinide is used for the management of Type 2 diabetes mellitus in adults, as an adjunct to diet and exercise and sometimes with other drugs for diabetes like metformin.

How it works

Repaglinide stimulates the pancreas to release more amount of the hormone insulin, which keeps the blood sugar level in control.

Common side effects

Nausea, Abdominal pain, Constipation, Eye disorder, Fall in blood sugar level, Hypersensitivity reaction, Itching, Rash, Urticaria, Vasculitis, Visual impairment, Vomiting, Diarrhoea
Metformin(500 mg)


Metformin is an antidiabetic medicine that helps to control blood sugar in people with type 2 diabetes mellitus.

How it works

Metformin belongs to class of medications called antidiabetics.It decreases the amount of glucose absorbed from the food and the amount ofglucose made by liver. Metformin also increases the body's response to insulin(a natural substance that controls the amount of glucose in the blood).

Common side effects

Flatulence, Muscle pain, Abdominal bloating, Chest pain, Skin rash, Flushing, Abdominal pain, Nail disorder, Diarrhoea, Headache, Indigestion, Bitter taste, Constipation, Allergic reaction, Heartburn


No substitutes found

Expert advice for EUREPA MF

  • Do not take the medicine if you are allergic to it or to any other content in the medicine.
  • Do not take repaglinide if you have type 1 diabetes or diabetic ketoacidosis (increased level of acid in the blood due to diabetes); liver or kidney disorder; serious infection or illness.
  • Avoid using repaglinide if you are pregnant or planning to become pregnant or breast-feeding.
  • Do not drive a vehicle or operate heavy machinery while taking the drug as it may cause dizziness due to changes in blood sugar level.

Frequently asked questions for EUREPA MF


Q. Is repaglinide a sulfonylurea drug?
Repaglinide belongs to a category of drugs called as meglinitinides. It is not a sulfonyl urea drug.
Q. What is repaglinide used for?
Repaglinide is used for the management of type 2 diabetes mellitus in adults.
Q. Is repaglinide safe?
Yes. Repaglinide is relatively safe if used as recommended. In case of any side-effects, consult your doctor.
Q. Does repaglinide cause weight gain?
Repaglinide may cause weight gain. If you experience any such symptoms, please consult your doctor.


Q. Is Metformin a birth control pill/ insulin / statin/ banned drug?
Metformin (also available as glyciphage, glycomet, glycomet SR) is an antidiabetic drug used in treatment of type 2 diabetes mellitus, particularly in overweight patients, as an adjunct to the diet and exercise.
Q. Is metformin safe?
Metformin is generally safe if used at prescribed doses for the prescribed duration as advised by your doctor.
Q. Can I take metformin forever?
Metformin should be taken at prescribed doses for the prescribed duration as advised by your doctor.
Q. Is metformin good for weight loss / weight loss in non-diabetics?
Metformin is used for the treatment of type 2 diabetes mellitus, particularly in overweight patients. 


Content on this page was last updated on 04 July, 2016, by Dr. Varun Gupta (MD Pharmacology)